On this page of StockholderLetter.com we present the latest annual shareholder letter from Citius Pharmaceuticals, Inc. — ticker symbol CTXR. Reading current and past CTXR letters to shareholders can bring important insights into the investment thesis.
Citius Pharmaceuticals, Inc. (CTXR) annual report filed on form 10k
 • shareholder letter icon 2/24/2026 Letter Continued (Full PDF)
 • stockholder letter icon 1/26/2024 CTXR Stockholder Letter
 • stockholder letter icon 1/27/2025 CTXR Stockholder Letter
 • stockholder letter icon More "Drugs & Pharmaceuticals" Category Stockholder Letters
 • Benford's Law Stocks icon CTXR Benford's Law Stock Score = 81


CTXR Shareholder/Stockholder Letter Transcript:

Citius Pharmaceuticals, Inc. (CTXR) annual report filed on form 10k

shareholder letter icon 2/24/2026 Letter Continued (Full PDF)
 

CTXR Stockholder/Shareholder Letter (Citius Pharmaceuticals, Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2026, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.